HC Wainwright Downgrades Humanigen On Disappointing COVID-19 Study – What’s Next
HC Wainwright downgraded Humanigen Inc (NASDAQ:HGEN) to Neutral from Buy and removed the price target based on the removal of COVID-19…
Amgen Touts Early Lumakras Combo Data In KRAS Cancer Settings
BMO Capital Markets says that while Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) + PD1i data was delayed to the August 7 presentation, it did get data on the Lumakras + SHP2 inhibitor combination.
Mizuho On Atara Biotherapeutics – Distinguish Between Small Numbers And Science Failure
Atara Biotherapeutics Inc (NASDAQ:ATRA) issued its anticipated interim analysis communication for its ATA188 Phase 2 progressive multiple sclerosis trial. Shares slumped…
Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test
Oncocyte Corporation (NASDAQ:OCX) completed the development and clinical validation of the Laboratory Test for its newly-branded VitaGraft Transplant Monitoring tests for…
Sanofi Offloads 17 Products To Neuraxpharm
Sanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum.
Merck Makes $290M Bet On Prostate Cancer Candidate
Merck & Co Inc (NASDAQ:MRK) and Orion Corporation announced a global development and commercialization agreement for Orion’s ODM-208 and other drugs targeting cytochrome…
Apollo Endosurgery’s New Obesity Endoscopic Systems Receive FDA Nod
Apollo Endosurgery Inc (NASDAQ:APEN) announced the marketing authorization of the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx…
Quest Diagnostics Unveils Monkeypox Test: What You Need To Know
Quest Diagnostics (NYSE: DGX) has announced the nationwide availability of a lab-developed, automated molecular diagnostic test to identify if a person is infected with monkeypox.
ABVC Biopharma Provides Enrolment Update In Mid-Stage Attention Deficit Disorder Study
ABVC Biopharma (NASDAQ: ABVC) provided an update on the enrollment progress in the Phase II Part II clinical study of its ADHD candidate (ABV-1505).
The Daily Biotech Pulse: AstraZeneca’s COVID-19 Vaccine As Effective As mRNA Shots, Humanigen’s Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth’s Alzheimer’s Program
Here's a roundup of top developments in the biotech space over the last 24 hours: